Papaverine 60mg Injection
By Papaverine
Rx
2ml Injection in a Ampoule
Composition
Papaverine(60mg)
Manufacturer - Mercury Laboratories Ltd
12-B, Girichhaya, Loyalka Estate, Chowpatty Band Stand, Mumbai - 400 006. INDIA
Expires on or after
July, 2025
When considering the use of Papaverine 60mg Injection, it is important to note that there is limited information about its safety in patients with liver disease. If you have liver impairment or liver disease, it is crucial to consult your doctor before using this medication. Papaverine Hydrochloride Injection should be approached with caution in individuals with liver impairment. If you have any concerns regarding your liver health, it is advisable to seek guidance from your healthcare provider before starting treatment with this medication.
Limited information on using Papaverine 60mg Injection in kidney disease. Consult your doctor if you have kidney issues or concerns.
It is not safe to drink alcohol while using Papaverine 60mg Injection. Alchohol may increase dizziness and drowsiness during treatment.
Papaverine 60mg Injection may cause dizziness and drowsiness. Avoid driving if you feel symptoms impacting focus and reactions. Operate machinery only when fully alert.
Papaverine 60mg Injection may not be safe during pregnancy, with limited human studies showing potential harm to the baby based on animal studies. Your doctor will assess benefits and risks before prescribing. Consult your doctor if pregnant or planning pregnancy.
It is better to consult your doctor before using Papaverine 60mg Injection.
Habit Forming | No |
Chemical Class | Benzylisoquinolines Derivative |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Phosphodiesterase (non specific) inhibitor |
₹23
Inclusive of all taxes
Content verified by
Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025